Documentation Centre

Flash required
October 10, 2012
Are there any promising developments regarding pharmacological approaches to managing global cardiometabolic risk in patients wity type 2 diabetes?
By Luc Van Gaal, MD, PhD, Professor of Medicine, Antwerp University Hospital, Faculty of Medicine, Department of Diabetology, Metabolism & Clinical Nutrition, Antwerp, Belgium [1:45 min.] [8MB]

  • See all Expert Opinions of Luc Van Gaal, MD, PhD, Professor of Medicine, Antwerp University Hospital, Faculty of Medicine, Department of Diabetology, Metabolism & Clinical Nutrition, Antwerp, Belgium

Download Video


Key Words
Diabetes, Cardiometabolic Risk, Weight Loss